GALD.SW
Price:
$166.6
Market Cap:
$39.12B
Galderma Group AG is engaged in cosmetic industry. Its segment includes Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology.
Industry
Household & Personal Products
IPO Date
2024-03-21
Stock Exchange
SIX
Ticker
GALD.SW
According to Galderma Group N’s latest financial reports and current stock price. The company's current ROE is 4.22%. This represents a change of 249.06% compared to the average of 1.21% of the last 4 quarters.
The mean historical ROE of Galderma Group N over the last ten years is -0.94%. The current 4.22% ROE has changed -546.98% with respect to the historical average. Over the past ten years (40 quarters), GALD.SW's ROE was at its highest in in the June 2025 quarter at 2.16%. The ROE was at its lowest in in the December 2023 quarter at -1.20%.
Average
-0.94%
Median
-1.67%
Minimum
-3.40%
Maximum
2.97%
Discovering the peaks and valleys of Galderma Group N ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 2.97%
Minimum Annual Increase = -378.36%
Minimum Annual ROE = -3.40%
| Year | ROE | Change |
|---|---|---|
| 2024 | 2.97% | -378.36% |
| 2023 | -1.07% | -53.18% |
| 2022 | -2.28% | -33.15% |
The current ROE of Galderma Group N (GALD.SW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.13%
5-year avg
-0.94%
10-year avg
-0.94%
Galderma Group N’s ROE is less than Chocoladefabriken Lindt & Sprüngli AG (13.40%), less than Chocoladefabriken Lindt & Sprüngli AG (13.40%), less than Barry Callebaut AG (6.96%), less than Emmi AG (21.82%), less than Bell Food Group AG (7.78%), less than Groupe Minoteries S.A. (4.60%), less than Aryzta AG (16.85%), greater than Orior AG (-140.03%), less than Villars Holding S.A. (2.49%),
| Company | ROE | Market cap |
|---|---|---|
| 13.40% | $26.52B | |
| 13.40% | $26.47B | |
| 6.96% | $6.54B | |
| 21.82% | $3.84B | |
| 7.78% | $1.39B | |
| 4.60% | $74.58M | |
| 16.85% | $1.28B | |
| -140.03% | $73.95M | |
| 2.49% | $61.07M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Galderma Group N using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Galderma Group N or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Galderma Group N's ROE?
How is the ROE calculated for Galderma Group N (GALD.SW)?
What is the highest ROE for Galderma Group N (GALD.SW)?
What is the 3-year average ROE for Galderma Group N (GALD.SW)?
What is the 5-year average ROE for Galderma Group N (GALD.SW)?
How does the current ROE for Galderma Group N (GALD.SW) compare to its historical average?